Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Allarity Therapeutics Announces Strategic Pivot To Focus Solely On Accelerating Stenoparib Toward Regulatory Approval; IXEMPRA And Dovitinib Development De-Prioritized

Author: Benzinga Newsdesk | March 27, 2024 08:33am

Posted In: ALLR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist